Objective: Resistin has been linked with obesity and hypothesized as a potential marker of insulin resistance in addition to being linked with acute inflammation. However, these links are still highly controversial in humans. Our goal was to examine resistin levels in relation to obesity, insulin resistance and inflammation markers in a large population of Asian children and adolescents. Methods: Children and adolescents (n ¼ 3472) aged 6-18 years, boys (n ¼ 1765) and girls (n ¼ 1707), were assessed for body size parameters, pubertal development, blood lipids, glucose, insulin, resistin, C-reactive protein (CRP), adiponectin and complement C3 (C3) levels. Results: Resistin increased with central obesity in both genders but not with simple adiposity in boys. Several markers associated with central obesity correlated in a gender-specific fashion with plasma resistin. Waist circumference, fat-mass percentage, waistto-height ratio and body mass index (BMI) positively correlated with resistin in both genders. Blood lipids such as triglycerides, nonesterified fatty acids (NEFA) and low-density lipoprotein cholesterol, diastolic and systolic blood pressure correlated positively with resistin in boys. NEFA, high-density lipoprotein cholesterol (negatively) and inflammation markers, such as CRP and C3, positively correlated with resistin in girls. There was no correlation between resistin and adiponectin, and no association of adiponectin with resistin quintiles in either boys or girls. In both boys and girls, resistin tended to decrease with age, with girls having higher levels than boys. Few indices of insulin resistance were linked with plasma resistin in either gender. Conclusion: In this population, plasma resistin levels are a weak biochemical marker of metabolic dysfunction defined by central obesity, adiposity and inflammation and does not predict insulin resistance. Only a small proportion of resistin variation can be explained by factors related to metabolic syndrome, suggesting that resistin is not strongly implicated in a concentrationdependent fashion in any of the examined pathologies.
Introduction
Resistin is a circulating 12.5 kDa protein of 114 amino acids that belongs to the resistin-like family. 1, 2 Considered an adipokine, resistin mRNA has been found in human adipose tissue and also in bone marrow, lung, nonfat cells of adipose tissue, placental tissue and pancreatic islets cells. [3] [4] [5] [6] [7] Resistin is regulated by insulin, glucose, growth hormone and thiazolidinediones. [8] [9] [10] [11] A resistin receptor, tissue distribution of a receptor or the specific signaling pathway is unknown. The main function of resistin remains unclear. Resistin was initially hypothesized as a link between obesity and insulin resistance. 1 In support of this theory, resistin is increased in mice with diet-induced obesity and in ob/ob mice. 1 Studies also showed that mice injected with recombinant resistin or overexpressing resistin had impaired glucose tolerance and insulin action. 1, [12] [13] [14] In addition, resistin was found to be an in vitro antagonist of insulin on human preadipocytes. 4 Human hepatic cells overexpressing resistin had impaired glucose uptake and glycogen synthesis. 15 By contrast, other groups have found the opposite or no correlation at all between resistin and insulin signaling. [16] [17] [18] Resistin, also identified as 'found in inflammatory zone 3', has been linked with inflammation. 19 It was positively correlated with pro-inflammatory factors in adults with pathophysiological conditions such as atherosclerosis, renal disease and inflammation of respiratory tracts. [20] [21] [22] [23] [24] [25] [26] [27] Proinflammatory molecules such as tumor necrosis factor-a, interleukin-6 and lipopolysaccharide regulate resistin gene expression in various cell models 28 and reciprocal modulation has been hypothesized. 29 Resistin is clearly involved in inflammation, but its specific function in that situation remains to be clarified. Many population studies suggest that resistin levels in adults are dependent on gender as women tend to have higher plasma resistin concentrations. [30] [31] [32] This finding was not supported by another study. 33 Resistin levels were also reported as not affected by age in adults. 33 Most studies also found an increase in resistin in obese adults when compared to lean groups with a positive correlation between resistin and obesity indices. 4, 29, 31, [33] [34] [35] Because of its link with obesity and inflammation and its potential link with insulin resistance, resistin has been tagged as a potential metabolic syndrome (MetS) marker. Supporting this theory, adults with MetS tend to have higher resistin levels than their healthy counterparts. 29 However, the correlation between insulin resistance and plasma resistin in adult humans remains controversial, supported by some studies 25, [35] [36] [37] and not in others, 4, 21, 34, 38, 39 and this therefore weakens the relation between resistin and MetS. Numerous other adipokines have been shown to be associated with obesity and insulin resistance. In particular, adiponectin decreases with obesity and insulin resistance, and its function is associated with maintenance of insulin sensitivity. 40 Thus, both resistin and adiponectin have been independently shown to be associated with insulin resistance, albeit in opposite directions. However, a clear functional link between these two hormones has yet to be extensively described, although suggested. Although some studies have found an inverse correlation between plasma levels of resistin and adiponectin, 36, [41] [42] [43] just as many others have found no statistical association 24, [44] [45] [46] [47] or a positive correlation. 48 All of these studies were conducted in adults.
The relationships found were still significant after correction for insulin resistance factors. To our knowledge, no mechanism explaining a possible negative reciprocal cooperation or regulation between these adipokines has yet been proposed. A positive correlation mechanism, mediated through tumor necrosis factor-a secretion, has been suggested as plasma concentrations of both adipokines are regulated by this inflammatory cytokine. 28, 49 Most of the studies mentioned previously evaluated plasma resistin levels in a small numbers of subjects (no350) and gender or obesity subgroups were relatively small for comprehensive statistical analysis. There is therefore little information about the relationship between resistin, inflammation, obesity and insulin resistance.
The prevalence of obesity in children and adolescents and the associated risks of developing type 2 diabetes mellitus have been increasing dramatically for several decades. 50 This relationship can be difficult to evaluate in children as acute insulin resistance consequent to obesity is usually only seen later in development. Resistin could potentially be a marker in obese children predicting the risks of transition to type 2 diabetes. As in adults, resistin levels in children tend to be higher in girls. 32, 51, 52 A negative correlation of plasma resistin and age has also been found, suggesting a link with development. 52 However, these relations with gender and age in children have not always been found. 31, 36, 42 In contrast of their adult counterparts, obese children were reported to have similar resistin levels when compared to lean children. 51, 52 These findings come from few studies and, to our knowledge, all of them also involved limited subject numbers (fewer than 350 subjects), limiting the potential for subgroup analysis. We evaluated resistin levels and parameters linked to obesity, insulin resistance, inflammation and MetS in 3472 Chinese children and adolescents (1765 boys, 1707 girls), aged from 6 to 18 years. We also evaluated the possible correlation between resistin and adiponectin plasma concentrations in children. We hypothesized that resistin levels could be related to obesity levels, but also linked with early insulin resistance symptoms, inflammation and adiponectin plasma levels in Asian children and adolescents. In particular, the associations in very young children were compared to those in adolescents. 
Methods

Subjects
Fasting blood samples
Venous blood samples were collected by direct venipuncture after an overnight (minimum 12 h) fast. The samples were centrifuged, aliquoted and immediately frozen for future analysis of lipids and hormones.
Analytical procedures
Samples were analyzed for concentrations of plasma glucose, insulin, nonesterified fatty acids (NEFA), complement C3 (C3), resistin, C-reactive protein (CRP), and serum TG, TC, high-density lipoprotein cholesterol (HDL-Chol) and lowdensity lipoprotein cholesterol (LDL-Chol). Plasma glucose was determined by the glucose oxidase method. Serum TC and TG concentrations were determined using standard enzymatic methods. HDL-Chol and LDL-Chol were measured directly. The serum lipid levels and plasma glucose were assayed using the Hitachi 7060C Automatic Biochemistry Analysis System. Plasma NEFA was determined by colorimetric enzymatic assay (Wako Chemicals, Tokyo, Japan). Plasma C3 concentration was determined by turbidimetric assay using a polyclonal anti-human antibody specific against C3 (Linfei Co., P.R. China). For this last assay (C3), intra-assay coefficient of variation (CV) was o4% and interassay CV was o8%. Insulin was measured by monoclonal antibody-based sandwich enzyme-linked immunosorbent assays (ELISA), 57 ) were prepared in 1% BSA-PBS. Plasma samples were diluted 1:500 in PBS. Twenty microliters of standards, diluted blood samples and quality control reagents were loaded. Biotin-labeled anti-adiponectin monoclonal antibodies (100 ml; diluted 1:1000) were added and incubated 1.5 h at 37 1C. The following steps were performed sequentially, with the plates washed between each step: (1) 100 ml of avidin-horseradish peroxidase solution (diluted 1:1000) was then added and incubated 30 min at 37 1C; (2) 100 ml of freshly mixed chromogenic substrate and development solution was added to each well, and plates were incubated 10 min at 37 1C and (3) 100 ml of 1 M H 2 SO 4 was added to stop the reaction and OD was measured at 450 nm. The sensitivity of the assay was 0.1 ng ml
À1
, the reaction was 100% specific to human adiponectin and intra-assay and inter-assay CVs were o5.4 and o8.5%, respectively. Serum resistin was measured using the ELISA kit by Phoenix Pharmaceuticals Inc. The intra-assay and inter-assay CVs of this assay were o10 and o5%, respectively. Gender-related differences in resistin levels The clinical and laboratory data of all the 3472 subjects distributed according to their gender are shown in Table 1 . Age, degree of pubertal development, height, weight, waist circumference, FMP, waist-to-height ratio, BMI, systolic and diastolic blood pressure, TG, HDL-Chol, fasting glucose and adiponectin significantly differed between boys and girls (plasma TG, Po0.05, other parameters, Po0.001). TC, LDLChol, fasting insulin, HOMA-IR and plasma NEFA were constant between genders. As seen in Figure 1 , resistin distribution is skewed among boys and girls. As shown in Table 1 , boys had slightly lower average resistin levels than girls (17.0 ± 0.2 vs 17.8 ± 0.2 ng ml Figure 1 , the genderrelated difference in plasma resistin levels was not quite significant when comparing prepubertal groups (average plasma resistin for boys and girls, 16.5 ± 1.2 vs 19.0±0.6 ng ml À1 , P ¼ 0.055), but was significant within pubertal group (average plasma resistin for boys and girls, 17.1 ± 0.3 vs 17.8 ± 0.3 ng ml
, P ¼ 0.005).
Age-related differences in resistin levels
In prepubertal children, overall, average resistin levels were higher (18.6 ± 0.6 ng ml
À1
) than in pubertal children (17.4 ± 0.2 ng ml À1 ). Resistin levels were negatively correlated with age (P ¼ 0.0003). This was also true when examining each gender separately (boys, P ¼ 0.003 and girls, P ¼ 0.021). Pubertal markers in boys and girls were also negatively correlated with plasma resistin levels, although to a lesser extent (testicular volume in boys, P ¼ 0.042, Tanner stage development in boys, P ¼ 0.096 and Tanner stage development in girls, P ¼ 0.046). Resistin linearly decreased with each Tanner stage when taking into account the whole cohort (P ¼ 0.0075). As showed in Figure 1 , resistin also decreased linearly with each Tanner stage for girls ( Figure 1f , P ¼ 0.015). This tendency was also observed in boys, but only after the first Tanner stage, at the onset of puberty (Figure 1e ,
Relations between resistin and obesity The population was then divided into quintiles based on resistin levels. Values for several biochemical and clinical Resistin and central obesity in children M Li et al factors for each quintile can be found in Table 2 for the whole cohort, in Table 3 for boys and Table 4 for girls.
A positive linear trend is observed between quintiles when comparing their average degree of obesity or BMI (for both, boys, Po0.0001 and girls, P ¼ 0.003). The highest resistin quintile in boys also showed a significantly increased degree of obesity (Po0.001), BMI (Po0.001), waist circumference (Po0.01), waist-to-height ratio (Po0.0001) and FMP (Po0.0001) compared to the first quintile. In girls, the fourth quintile showed, but to a lesser extent, an association with increased degree of obesity (Po0.05), BMI (Po0.05), waist circumference (Po0.05), waist-to-height ratio (Po0.01) and FMP (Po0.01) compared to the first quintile. In addition, subgroups based on the degree of obesity showed a significant increase in average plasma resistin levels for obese vs normal weight children (18.2 ± 0.3 vs 16,9 ± 0.3 ng ml À1 , Po0.0001). This increase was also true in boys, as seen in Figure 2 Resistin and central obesity in children M Li et al Po0.0001). The same increase was observed in obese vs normal weight girls, but to a lesser extent (18.5±0.5 vs 17.4±0.3 ng ml
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À1
, P ¼ 0.007). Consistent with obesity associations, Pearson's analysis showed that several obesity markers were positively correlated with resistin levels. In boys, waist-to-height ratio (Po0.0001), FMP (Po0.0001), BMI (P ¼ 0.0002) and waist circumference (Po0.0007) all correlated with plasma resistin levels. None of these associations was found when exclusively analyzing the male prepubertal group. In girls, waistto-height ratio (P=0.0002), FMP (P ¼ 0.006), BMI (P ¼ 0.010) and waist circumference (P ¼ 0.026) were positively correlated with resistin plasma levels. None of these associations was found when exclusively analyzing the female prepubertal group. Spearman's analysis indicated that the degree of obesity also correlated positively with plasma resistin in both genders (boys, Po0.0001 and girls, P ¼ 0.002).
Relations between resistin and blood lipids and pressure Blood lipids such as plasma TG (P=0.0005), plasma NEFA (P ¼ 0.003) and LDL-Chol (P ¼ 0.041) positively correlated with resistin in boys ( Table 3 ). The fifth quintile of resistin in boys showed increased TG (Po0.01) and NEFA (Po0.01) when compared to the first quintile. No correlation relative to blood lipids was found when only analyzing the prepubertal boys group. In girls, NEFA (P ¼ 0.009) positively correlated with resistin and HDL-Chol (P ¼ 0.024) negatively correlated (Table 4 ). There was no significant difference in girls resistin quintiles in relation to blood lipids. Only HDLChol negatively correlated with resistin in the female prepubertal group (P ¼ 0.012).
In boys, blood pressure components such as diastolic blood pressure (P ¼ 0.002) and systolic blood pressure (P ¼ 0.003) were also positively and significantly correlated with plasma resistin. In girls, no link between resistin and blood pressure was observed.
Relations between resistin and glucose metabolism For boys, linear regression analysis showed that resistin levels surprisingly correlated negatively with glucose (P ¼ 0.003), but that insulin levels (P ¼ 0.106), HOMA-IR (P ¼ 0.229) and presence of IFG (P ¼ 0.136) did not correlate with blood resistin (Table 3 ). The same tendencies were observed if only examining the prepubertal boys. For girls, none of the aforementioned factors correlated with resistin (glucose, P ¼ 0.089, insulin levels, P ¼ 0.945, HOMA-IR, P ¼ 0.904 and presence of IFG, P ¼ 0.159; Table 4 ). However, in the prepubertal girls subgroup, insulin levels strongly and Resistin and central obesity in children M Li et al positively correlated with plasma resistin (Po0.0001). There was no correlation between resistin and adiponectin in either the whole cohort (Table 2 ) or in boys and girls separately (Tables 3 and 4) .
Relations between resistin and MetS
As shown previously, several MetS markers were correlated with resistin levels in a gender-specific way, including blood pressure, plasma TG, glucose, HDL-Chol and degree of obesity. We evaluated the average plasma resistin in groups based on the number of positive MetS components. When pooling both sexes, resistin levels were significantly increased in children with two and with three and more MetS components (for both, Po0.01). We also evaluated the relation between plasma resistin and presence of specific MetS components. In boys, presence of central obesity (Po0.0001), high blood pressure (HBP) (Po0.0001), high triglyceride (HTG) (P ¼ 0.003), number of MetS components (Po0.0001) and presence of MetS (P ¼ 0.001) was correlated with resistin plasma levels ( Table 3) . When exclusively analyzing the male prepubertal group, none of these associations was found. In girls, presence of central obesity (P ¼ 0.001), presence of LHDL (P ¼ 0.019) and number of MetS components (Po0.003) correlated with plasma resistin levels ( Table 4 ). In the prepubertal girls, only LHDL correlated with resistin (P ¼ 0.034).
We evaluated the average plasma resistin in presence of each specific (but not exclusive) type of MetS component and analyzed the differences between each MetS component group and control group (number of MetS component ¼ 0). ). Groups with IFG and LHDL showed levels comparable to the control group. In girls, only those positive for central obesity had significantly elevated average resistin levels compared to the healthy control group (18.6±0.4 and 17.4±0.4 ng ml À1 , respectively; Po0.05).
We subsequently divided the above MetS-specific component subgroups based on pubertal development (Tanner stages). The increases in plasma resistin in boys with central obesity, HTG or HBP were consistently observed in each stage of puberty (Po0.01 for all three parameters). Average resistin levels in boys with MetS components were also consistently higher than those without MetS components, throughout puberty. However, the increase in plasma resistin levels of boys with central obesity tended to be located primarily in the central Tanner stages (2-4) and therefore might be related to interactions between Tanner stage and MetS component (P ¼ 0.050). Prepubertal boys (Tanner stage 1) or boys that completed their puberty (Tanner stage 5) tended to have similar or slightly elevated average resistin levels when positive to the aforementioned MetS components. No such relation could be observed in girls, where average resistin levels were consistently higher in girls with central obesity independently of their pubertal stage (Po0.01) and with no interaction between Tanner stage and MetS component.
To further distinguish the effects of central obesity on plasma resistin levels, we divided the population into three groups based on obesity index as described earlier. We then further divided these groups into two subgroups, negative or positive for central obesity (Figure 4) . Children with central obesity had consistently increased resistin levels compared to those without central obesity, regardless of obesity index. Overweight or obese children with central obesity had significantly increased resistin when compared to lean children (Po0.01 and Po0.001, respectively), but overweight or obese children without central obesity had similar resistin levels. We then further divided our population based on gender. As shown in Figure 4a , boys with central obesity had a consistently elevated resistin compared to their counterparts without central obesity (Po0.01). Girls with central obesity also tended to higher average plasma resistin levels than those without central obesity, but the difference was not significant and only observed in lean or overweight girls (Figure 4b ). Obese girls had elevated resistin levels compared to lean girls regardless of central obesity.
We also evaluated the combined effects of puberty and central obesity by dividing the population according to Tanner stage, and then further dividing the group in two subgroups, negative or positive for central obesity. Resistin levels were significantly increased in the presence of central obesity (Po0.001), with significant increases at Tanner stages 2-4 (Po0.01 for all). When divided based on gender, as shown in Figures 4c and d , plasma resistin in boys with central obesity was also globally higher than their counterparts regardless of Tanner stage (Po0.01). Plasma resistin moderately increased with central obesity in Tanner stages 2 and 4 (Po0.05) and strongly increased in Tanner stage 3 (Po0.001). In girls, resistin was also globally increased in the presence of central obesity (Po0.01), but the specific differences between each pubertal subgroup were not as consistent as with the boys. The only significant increase between subgroups was seen in the fourth Tanner stage (Po0.05).
We subsequently verified resistin contribution to HOMA-IR after correction for waist circumference. In these circumstances, resistin did not significantly contribute to predicting HOMA-IR in boys. However, after correction, resistin still contributed to predicting HOMA-IR in girls, but in a linearly negative way (P ¼ 0.037). The contribution was extremely small (o1%).
Relations between resistin and inflammation
In boys, there was no correlation between plasma resistin and pro-inflammatory molecules such as C3 or CRP. Previously, a C3 cutoff point of 1.8 g l À1 has been used to differentiate varying levels of coronary artery disease and vascular events. 60 Similarly, in boys with high C3 levels (X1.8 g l À1 ), no difference was found in average resistin levels and no group-specific correlation could be made between resistin and obesity, insulin resistance or MetS markers. However, significant positive correlations were found in girls between resistin and C3 (P ¼ 0.009) or CRP (P ¼ 0.004) after puberty onset (Tanner stages 2-5). In girls with pathological C3 levels, resistin was positively correlated with IFG (P ¼ 0.003). In the same group, Pearson's analysis showed a link between resistin and fasting plasma glucose (P ¼ 0.023), but not with any other factor including obesity markers. They also had higher average resistin levels compared to girls with nonpathological C3 levels (18.9 ± 0.8 vs 17.3 ± 0.5 ng ml
À1
), but the difference was not significant (P ¼ 0.316).
Predicting plasma resistin values
Forward stepwise regression showed that resistin levels for boys can be predicted (R ¼ 0.161) using a linear combination of age (Po0.001), weight (Po0.001), fasting glucose (P ¼ 0.033), degree of obesity (P ¼ 0.006) and testicular volume (P ¼ 0.020). In prepubertal boys, no factor significantly predicted resistin levels. Resistin levels for girls can be In prepubertal girls, FMP (P ¼ 0.027) and IFG (P ¼ 0.028) significantly predicted resistin levels (R ¼ 0.306). Overall, obesity, insulin resistance and pubertal markers are the best predictors for resistin levels variation in both boys and girls, although the contribution is low.
Discussion
Gender-specific differences As suggested previously in the literature, girls in our study also had higher average plasma resistin than boys. Interestingly, the difference seems more important in prepubertal children, despite the nonsignificant analysis. The difference between average resistin levels in girls and boys decreased through pubertal stages but might remain in adulthood, as previously proposed. Evidence, such as the significant expression of resistin mRNA in human maternal placenta, 6 resistin regulation by gonadal hormones 61 and genderrelated increase in resistin mRNA found in mice 1 or rat adipose tissue 61 suggests that the molecular pathway by which resistin levels are controlled could differ between males and females. This information could potentially explain the disparity between genders in resistin associations and stepwise regression analysis results. The very low amount of resistin variation explained with our analysis also suggests that the main resistin determinants are still unknown and that the parameters measured are indirectly related. Realizing a stepwise regression with these factors, as many of them are known to be modulated differently by subtle and intrinsic gender-specific changes in lipid and carbohydrate metabolism, would obviously result again in important disparity between genders.
Age relation
Many hormones such as ghrelin, leptin and adiponectin have been related to development, 62 and resistin is now also a likely candidate. A strong link between resistin and development has been found in rats, where resistin mRNA was found to reach a peak at puberty and then decrease in the adipose tissue. 61 As mentioned previously, increased maternal resistin levels through placental production also show evidence of a relationship between resistin and development. In the present study, our large sample size allowed us to find an inverse correlation that most other studies did not find, suggesting that human resistin levels decrease with age and puberty in both genders. In adults, resistin levels may no longer correlate with age, as reported in other studies. As in mice or rats, the mechanism by which this is achieved remains unidentified in humans.
Obesity correlation
Plasma resistin correlated very strongly with many obesity markers in the present study, independently of gender and Resistin and central obesity in children M Li et al age, with waist-to-height ratio and FMP being the strongest factors. We have been able to distinguish the effects of simple elevated adiposity vs central obesity in the present study. There seems to be no increase in plasma resistin strictly related to adiposity alone in boys. However, the presence of central obesity in boys strongly associated with high resistin levels. In girls, adiposity and central obesity both contributed to elevated plasma resistin, providing another interesting gender-specific difference. The association of central obesity with resistin is supported in both genders by the strong linear correlation between plasma resistin and waist-to-height ratio, a good pediatric physical indicator of central obesity. Also supporting our findings, the amount of resistin mRNA expressed by visceral and subcutaneous abdominal fat was found vastly superior to that found in thigh or breast fat. 63 Insulin resistance correlation Predicting the risk of developing insulin resistance and type 2 diabetes is increasingly important in every country, especially in the developing world. In China, diabetes among children is increasing in a dramatic way. In 2030, it is projected that diabetes prevalence will double in the Chinese adult population. 50 In addition, Asian children have been found to be more prone to show impaired fasting glucose and high fasting insulin than Caucasian children. 64 With resistin labeled as a potential insulin resistance marker, our study examined these relationships. To date, few studies have shown a positive correlation between insulin resistance markers and resistin in adults, and none has showed it in children. Moreover, very few children-specific studies have identified factors that could be related to the development of insulin resistance. Some studies have implicated fat distribution as a factor, as many children with central obesity show insulin resistance. 65 However, it has been suggested that, in children, overall adiposity is a better insulin resistance marker. 66, 67 In the present study, there was no further increase of resistin when IFG was present in addition to central obesity, and independent resistin contribution to insulin resistance seemed inexistent or very small. Our large number of subjects allowed us to look extensively at many parameters to identify any significant differences. However, very little association was found between resistin and insulin resistance. Resistin is therefore, independently of gender or age, not an independent predictor of an obese and insulinresistant phenotype in children. However, we cannot rule out that resistin could still have a function in the development of a dysfunctional insulin signaling pathway. The lack of association between resistin and adiponectin is an interesting one considering the proposed, although not definitive, functions of these adipokines in protecting from (adiponectin) or promoting (resistin) insulin resistance. However, considering that insulin resistance parameters and plasma resistin concentrations in our study were independent, the absence of correlation with adiponectin is not that surprising. In fact, based on literature searches, the lack of correlation between these two parameters is quite common, 24, [44] [45] [46] [47] leading us to hypothesize that although both adipokines may have specific functions in metabolism generally related to obesity and insulin homeostasis, their functions may be distinctly different and often unrelated.
MetS correlation
Although some studies found links between MetS and resistin in adults, none to our knowledge has found a correlation in children. Interestingly, our sample size allowed us to find specific correlations among our groups. In boys, plasma resistin is strongly correlated with three MetS components: central obesity, HBP and HTG. Therefore, although resistin is globally a good predictor of MetS for boys, it is closely related only to some factors implicated in the diagnosis of MetS. For girls, central obesity was the only determining factor related to the MetS that was positively correlated with high resistin levels. Plasma resistin is therefore a weak MetS predictor, particularly in girls.
Inflammation factors
The presence of inflammatory cytokines tends to increase with age throughout adult life. 68 However, resistin levels follow the opposite path in children and remain stable in adulthood, which indicates that resistin levels are not solely regulated by pro-inflammatory molecules as has been previously suggested. As many studies have shown in an adult population, we also found that resistin is increased in children with acute inflammation, but in a gender-dependent fashion. Interestingly, pubertal girls with acute inflammation showed no correlation between resistin levels and obesity markers, suggesting that the effects of pro-inflammatory molecules on resistin levels were not dependent on obesity. On the other hand, the strong correlation of resistin with central obesity, which is associated with inflammation, 69 suggests that the increased plasma resistin observed in children with central obesity is linked to that proinflammatory state, which may emerge at a later time point. Supporting this idea, resistin is expressed at the highest levels in macrophages, cells of the immune system found in higher amount in adipose tissue in central obesity. 70, 71 Macrophages could therefore be another source contributing to the increased plasma resistin levels found in subjects with central obesity. It is relevant to note that an increase in inflammatory markers is not correlated with insulin resistance in children 66 and that resistin, therefore, cannot be linked with insulin resistance through inflammation.
Conclusion
Our study was able to demonstrate that the typical profile of an Asian male child with high resistin levels (fifth quintile) is more likely to display increased waist circumference, FMP,
Resistin and central obesity in children M Li et al diastolic blood pressure, plasma TG and plasma NEFA. Very high levels of resistin are a global indicator of metabolic dysfunctions associated with visceral obesity in boys. On the other hand, the typical profile of an Asian girl with high resistin levels is less alarming. Resistin levels above the median are a weak predictor of adiposity, translated by mildly increased waist circumference, BMI and FMP.
Children of either gender with high plasma resistin are not more likely to show insulin resistance. Classical markers such as plasma TG, HDL-Chol, LDL-Chol, fasting glucose or fasting insulin are far better markers than resistin for most parameters related to obesity, MetS and insulin resistance in the present cohort. Moreover, resistin seems to be strongly correlated with variables that are easily measurable by physical examination, such as obesity, FMP and blood pressure. Although resistin is not closely associated with global metabolic dysfunctions, it is a marker of fat distribution because it is specifically associated with abdominal fat depots. This correlation with central obesity could also be a link between the function of resistin in obesity and inflammation, mediated by macrophages. The elevated plasma resistin levels observed in children with central obesity, a known determinant of insulin resistance development in adults, 72 could also be the indirect link between resistin and insulin resistance as the children mature to adults. The nature of the direct link between insulin resistance metabolism and resistin in humans, if there is any, remains unclear. Despite our large population, our study was not able to find any indices, supporting the existence of such a direct link in Asian children. With the very small amount of variation in resistin levels that can be explained with the parameters mentioned throughout our study, it is likely that resistin is implicated in a related pathway but that its main function remains unknown. The lack of information about resistin receptor prevents us from drawing stronger conclusions, as alterations to resistin sensitivity through receptor regulation could have an important function.
